Literature DB >> 3710688

Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.

S Meryn, D Stein, E W Straus.   

Abstract

The influence of morbid obesity and gastric bypass operation on pancreatic polypeptide (PP), pancreatic glucagon and enteroglucagon was studied in six morbidly obese patients before and 6-9 months after surgery. Hormone plasma levels were determined in the fasting state and after a standardized test meal. Fasting levels of PP, pancreatic glucagon and enteroglucagon were not significantly different between the pre- and post-operative state as well as compared to normal controls. The postprandial response showed a significant reduction of PP, a significant increase of enteroglucagon and no change of pancreatic glucagon after surgery compared with the preoperative values.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3710688

Source DB:  PubMed          Journal:  Int J Obes


  9 in total

Review 1.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Changes in Enterohepatic Circulation after Duodenal-Jejunal Bypass and Reabsorption of Bile Acids in the Bilio-Pancreatic Limb.

Authors:  Ichiro Ise; Naoki Tanaka; Hirofumi Imoto; Masamitsu Maekawa; Atsushi Kohyama; Kazuhiro Watanabe; Fuyuhiko Motoi; Michiaki Unno; Takeshi Naitoh
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

3.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

Review 4.  Potential of surgery for curing type 2 diabetes mellitus.

Authors:  Francesco Rubino; Michel Gagner
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 5.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

Review 6.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

7.  PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

Authors:  Benjamin C T Field; Alison M Wren; Veronique Peters; Kevin C R Baynes; Niamh M Martin; Michael Patterson; Sara Alsaraf; Vian Amber; Katie Wynne; Mohammad A Ghatei; Stephen R Bloom
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

Review 8.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

Review 9.  Surgery for obesity: a review of the current state of the art and future directions.

Authors:  Stephen S McNatt; James J Longhi; Charles D Goldman; David W McFadden
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.